BOLZATI, CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 2.987
NA - Nord America 1.109
SA - Sud America 646
EU - Europa 452
AF - Africa 53
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.252
Nazione #
SG - Singapore 1.266
US - Stati Uniti d'America 1.036
CN - Cina 682
BR - Brasile 523
HK - Hong Kong 357
VN - Vietnam 280
KR - Corea 179
NL - Olanda 105
IT - Italia 97
GB - Regno Unito 56
IN - India 49
AR - Argentina 48
DE - Germania 35
CA - Canada 34
JP - Giappone 29
FI - Finlandia 25
MX - Messico 23
FR - Francia 22
ID - Indonesia 22
IL - Israele 21
BD - Bangladesh 18
CO - Colombia 17
PL - Polonia 17
RU - Federazione Russa 15
ZA - Sudafrica 14
EC - Ecuador 13
IQ - Iraq 13
VE - Venezuela 11
BE - Belgio 10
PK - Pakistan 10
PY - Paraguay 10
ES - Italia 9
PE - Perù 9
PH - Filippine 9
EG - Egitto 8
UA - Ucraina 8
BG - Bulgaria 7
UY - Uruguay 7
UZ - Uzbekistan 7
CL - Cile 6
GR - Grecia 6
IE - Irlanda 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
KG - Kirghizistan 5
LT - Lituania 5
SA - Arabia Saudita 5
SE - Svezia 5
TR - Turchia 5
CH - Svizzera 4
JM - Giamaica 4
MA - Marocco 4
CZ - Repubblica Ceca 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
SN - Senegal 3
TH - Thailandia 3
AT - Austria 2
AU - Australia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 5.247
Città #
Singapore 780
Santa Clara 470
Hefei 356
Hong Kong 354
Seoul 178
Beijing 136
Ho Chi Minh City 83
Hanoi 64
Dallas 56
San Jose 56
Ashburn 50
Los Angeles 46
São Paulo 44
Guangzhou 37
Buffalo 23
Minamishinagawa 20
Rio de Janeiro 19
Brasília 16
New York 16
Bengaluru 15
Toronto 15
Warsaw 14
Biên Hòa 12
Frankfurt am Main 12
Helsinki 12
Haiphong 11
Hải Dương 11
London 11
Belo Horizonte 10
Da Nang 9
Phoenix 9
Brussels 8
Goiânia 8
Brooklyn 7
Campinas 7
Lima 7
Milan 7
Munich 7
Ottawa 7
Padova 7
Recife 7
Tokyo 7
Verona 7
Athens 6
Belém 6
Chicago 6
Curitiba 6
Dublin 6
Guarulhos 6
Johannesburg 6
Lappeenranta 6
Manaus 6
Montreal 6
Rome 6
Salvador 6
Tashkent 6
Asunción 5
Atlanta 5
Baku 5
Bình Dương 5
Can Tho 5
Düsseldorf 5
Fortaleza 5
Ha Long 5
Manchester 5
Poplar 5
Quận Bình Thạnh 5
Turku 5
Bishkek 4
Contagem 4
Dhaka 4
Glasgow 4
Guayaquil 4
Houston 4
Itajaí 4
João Pessoa 4
Mexico City 4
Montevideo 4
Moscow 4
Natal 4
Philadelphia 4
Porto Velho 4
Quận Một 4
Quận Năm 4
Sofia 4
Southwark 4
São Gonçalo 4
Uberlândia 4
Venice 4
Alegrete 3
Alexandria 3
Americana 3
Amman 3
Amsterdam 3
Ankara 3
Aracaju 3
Baghdad 3
Boston 3
Buenos Aires 3
Bắc Giang 3
Totale 3.286
Nome #
Copper(II) and copper(I) complexes with a bidentate hydrazinic dithiocarbazate: synthesis and crystal structures 78
Pharmacological characterization of alpha-MSH-derivatives 75
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 73
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 72
N, n-(dialkylamino)-alkyl substituted Tc-99m-amineamidedithiol (AADT) complexes as diagnostic probes for melanoma. 68
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 67
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 62
Evaluation of [99mTc]Tc(CO)3+ moiety labeled ?-melanocyte stimulating hormone derived peptide conjugatesfor potential melanoma imaging 56
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 53
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer 53
Compendio di radiochimica e radiofarmacia : Radiofarmaci marcati con tecnezio-99m 52
Oxo-rhenium(V) mixed-ligand complexes with bidentate functionalized phosphines and tridentate Schiff base ligands 51
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 50
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and Tc-99m-radiolabelling 49
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 48
IMPACT OF DIFFERENT [Tc(N)PNP]-FRAMEWORKS ON THE PHARMACOKINETICS OF THE SMALL RGDFK PEPTIDE 46
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 45
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 44
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 44
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 44
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 43
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 43
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 42
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 42
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 40
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 40
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 40
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 40
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 39
Radioactive Transition Metal Nitride Hetero-Complex 39
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 39
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 39
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 38
[ 99m Tc][Tc(N)(DASD)(PNP n)] + (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies 38
[99mTc][Tc(N)PNP]-tagging of the small RGDfK peptide: impact of different PNP structures on the labeling and pharmacokinetics of the radioconjugates 38
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 38
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 37
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 37
Preclinical dosimetric studies of Lu-177-scFvD2B and comparison with Lu-177-PSMA-617 and Lu-177-iPSMA endoradiotherapeutic agents 37
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 37
SITE-SPECIFIC [99mTc][Tc(CO)3(OH2)3]-LABELED scFvD2B-HysTag FOR SPECT IMAGING OF PSMA IN PROSTATE CANCER 37
(Radio)pharmacological characterization of novel alpha-MSH derivatives 37
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 36
Radiopharmacological characterization of 64Cu-labeled alfa-MSH analogs for potential use in imaging of malignant melanoma 36
Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer 36
Water-Soluble [Tc(N)(PNP)] Moiety for Room-Temperature 99mTc Labeling of Sensitive Target Vectors 36
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 35
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 35
Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands 35
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 35
Synthesis, Characterization, and Initial Biological Evaluation of [99mTc]Tc-Tricarbonyl-labeled DPA-?-MSH Peptide Derivatives for Potential Melanoma Imaging 35
'3+1' mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: Synthesis and evaluation in vitro and in vivo 34
Cu-64-labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 34
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 34
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 34
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 34
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 34
Zirconium immune-complexes for PET molecular imaging: Current status and prospects 33
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 33
Mixed Technetium-99m Nitrido Complexes with Dithiocarbamate and Phosphine-Thiol Ligands 32
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 32
A Bis(Thiosemicarbazone) bifunctional chelating agent for Nitrido-Tchnetium-99m and Copper 64-basedRadiopharmaceuticals 32
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 32
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 31
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules 31
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry 31
Nitrido technetium-99m core in radiopharmaceutical applications: Four decades of research 31
Synthesis, characterization and in vitro cytotoxicity of gallium(iii)-dithiocarbamate complexes 31
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 30
The emerging value of Cu-64 for molecular imaging and therapy 30
, [188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 30
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 29
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 29
Low-Valent Technetium Complexes with Aminodiphosphines 28
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 28
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 28
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 27
The emerging value of copper-64 for molecular imaging and therapy. 27
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 27
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 27
Cu-64-dithiocarbamate compounds for theragnostic applications: Preliminary in-vitro studies 26
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 26
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 26
Radiochemical and radiopharmacological characterization of a Cu-64-labeled alpha-MSH analog conjugated with different chelators 26
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 26
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 25
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 25
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 25
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 25
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 25
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 24
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 24
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 24
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 24
Radiation effective dose assessment of [51Mn]- and [52Mn]-chloride 24
[Tc-99m(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 24
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 23
SYNTHESIS AND CHARACTERIZATION OF NEUTRAL TECHNETIUM(III) COMPLEXES WITH MIXED S,P-BIDENTATE PHOSPHINE THIOLATE LIGANDS - CRYSTAL-STRUCTURE OF [TC(SCH2CH2PPH2)2(SCH2CH2PPH2O)] 23
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 23
SYNTHESIS OF TECHNETIUM COMPLEXES WITH A P,N BIDENTATE PHOSPHINE AMINE LIGAND - CRYSTAL-STRUCTURE OF BIS[(O-AMIDO-PHENYL)DIPHENYLPHOSPHINE-KAPPA-N,P][(O-AMINOPHENYL)-DIPHENYLPHOSPHINE-KAPPA-N,P]TECHNETIUM(III) PERCHLORATE 23
Totale 3.693
Categoria #
all - tutte 20.025
article - articoli 12.486
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 370
Totale 32.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202470 0 0 0 0 0 0 0 0 2 0 66 2
2024/20252.579 20 10 198 109 418 118 60 158 75 116 707 590
2025/20262.637 242 390 445 664 692 144 60 0 0 0 0 0
Totale 5.286